Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded by a diverse group of scientists, physicians, entrepreneurs, and investors, Vida Ventures, LLC is a prominent life sciences investment firm with a strong focus on advancing transformative biomedical innovations. Established with a mission to significantly impact patients' lives, the firm operates from multiple locations across the United States, including Los Angeles, Fort Worth, Boston, and New York. With approximately $1.8 billion in assets under management, Vida Ventures employs a flexible investment strategy that allows them to support companies at various stages of development, from early-stage startups to established commercial enterprises. The firm is well-regarded in the venture capital community for its deep expertise in the life sciences sector, particularly in therapeutics, and its commitment to fostering innovation that can lead to groundbreaking medical advancements.
Vida Ventures specializes in the life sciences sector, with a particular emphasis on therapeutics. The firm is open to investing in companies at any stage of development, including Friends and Family, Angel, Accelerator, Pre Seed, Seed, Seed Plus, Series A, Series B, Series C, and Growth Equity. This broad investment spectrum allows Vida Ventures to engage with a diverse range of companies, from nascent startups to more mature organizations. Their investment thesis is deeply informed by the extensive experience of their team, which includes professionals with backgrounds in science, medicine, and entrepreneurship. This unique perspective enables Vida Ventures to provide tailored support to companies throughout the entire continuum of discovery and development, ensuring that they can navigate the complexities of bringing innovative therapeutics to market.
Vida Ventures boasts a robust portfolio of notable companies that exemplify its commitment to advancing life sciences. Among its key investments are **A2 Biotherapeutics**, which is pioneering advanced biologics technology for next-generation immunotherapies; **Aktis Oncology**, focused on developing targeted radiopharmaceuticals for solid tumor cancers; and **Allogene Therapeutics**, known for its innovative allogeneic CAR T therapies for cancer treatment. Other significant portfolio companies include **Halda Therapeutics**, which is developing RIPTAC™ cancer therapies; **Kyverna Therapeutics**, dedicated to cell therapies for autoimmune diseases; **Protego Biopharma**, which seeks solutions for protein misfolding diseases; and **Scorpion Therapeutics**, engaged in precision medicine for oncology. This diverse portfolio reflects Vida Ventures' strategic focus on transformative biomedical innovations that have the potential to significantly improve patient outcomes.
To pitch Vida Ventures, please email info@vidaventures.com. They welcome pitches from founders and prefer clear, concise presentations that outline the business model, market potential, and alignment with their investment focus in life sciences and therapeutics.
Recently, Vida Ventures congratulated Aktis Oncology on its successful entry into the public markets, highlighting their commitment to supporting innovative companies in the life sciences sector. Additionally, they announced the launch of Poplar Therapeutics, which secured $50 million in Series A funding to develop a new class of anti-IgE therapy. These activities underscore Vida Ventures' active engagement in the life sciences ecosystem.
Vida Ventures invests across a wide range of stages, including Friends and Family, Angel, Accelerator, Pre Seed, Seed, Seed Plus, Series A, Series B, Series C, and Growth Equity. This flexibility allows them to support companies at various points in their development journey.
Founders interested in pitching to Vida Ventures can reach out via email at info@vidaventures.com. It is advisable to provide a clear overview of the business model, market opportunity, and how the proposed innovation aligns with Vida's focus on life sciences and therapeutics.
Vida Ventures primarily focuses on the life sciences sector, with a strong emphasis on therapeutics. They are particularly interested in companies that are developing innovative solutions in biotech and healthcare.
While specific check sizes are not detailed, Vida Ventures invests across various stages, indicating a flexible approach that can accommodate different funding needs, from early-stage investments to larger growth equity rounds.
Vida Ventures operates across multiple locations in the United States, including Los Angeles, Fort Worth, Boston, and New York, allowing them to engage with a broad range of companies in the life sciences ecosystem.
Vida Ventures leverages its extensive network and expertise in the life sciences sector to provide valuable insights and resources to its portfolio companies, helping them navigate the complexities of development and commercialization.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.